Article

Description of Resource:

Multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and certain gram-negative bacilli, have important infection control implications that either have not been addressed or received only limited consideration in previous isolation guidelines. Increasing experience with these organisms is improving understanding of the routes of transmission and effective preventive measures. The guideline provides recommendations for the implementation of strategies and practices to prevent the transmission of MRSA, VRE, and other MDROs.

Evidence-Based Resource Details

Learn more about EBR criteria

Developed By:

Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee

Developer Type:

Federal Government

Healthy People 2020 Topic Area(s):

Healthcare-Associated Infections

Healthy People 2020 Objectives:

HAI-2

Resource Type:

Systematic Review

Expert Opinion

Citation:

Siegel J, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006 [Internet]. 2006 [cited 2013 Feb 28]. Available from: http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf

Tags:

Effect Health System Change, Reduce Morbidity, Reduce Mortality, Reduce Risk or Incidence of Disease or Condition, Public Health, Healthcare, Clinical Practice, Environmental & Policy, Primary Prevention, Healthcare Providers, Patients

Syndicated Content Details:
Source URL: https://www.healthypeople.gov/2020/tools-resources/evidence-based-resource/management-multidrug-resistant-organisms-health-care
Source Agency: Office of Disease Prevention and Health Promotion, Healthy People (ODPHP-HP)
Captured Date: 2016-06-09 16:00:35.0